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We have investigated 17 patients with two diphosphonate scans of their hands one year apart as we were also concerned with the value of a single isotope scan. We have calculated the scintigraphical activity of each joint. maximum score 4, using a similar scoring system and visual assessment ( Table 1) .
The results support our original report, showing no apparent association between the uptake of isotope and the development of erosions. Even when nine patients with early disease (mean 20 months) were examined a similar pattern of isotope uptake was found.
It is possible that the high proportion of joints reported by the above authors, showing increased uptake, reflects increased disease activity. We note that 47% of these highly active joints on isotope scanning have not developed erosions during the study.
We believe our original observation that increased uptake of isotope may be associated with some, but not all erosions, still stands and that isotope uptake probably reflects other processes of acute inflammation unassociated with the development of an erosion. If the hepatic enzyme rises are accepted as probably drug induced, however, there is a more important aspect to note, namely the lack of a clinical hypersensitivity reaction. All but one' of the 17 cases in the literature of sulphasalazine hepatotoxicity in inflammatory bowel disease showed such a reaction, comprising fever, lymphadenopathy, and peripheral eosinophilia. We wish to draw your readers' attention to another rheumatoid patient who developed sulphasalazine hepatotoxicity, in whom this hypersensitivity reaction was also notably absent.
Case history
A 50 year old woman with rheumatoid arthritis developed anorexia, nausea, and upper abdominal pain after 11 weeks of sulphasalazine therapy at a dose of 3 g/day. She was anicteric and had no fever, lymphadenopathy, skin rash, or any stigmata of liver disease. Hepatic transaminases, which had been normal immediately before treatment, were now markedly raised (see Table) . There was no history of jaundice, hepatitis contact, or blood transfusion, she had not travelled abroad, and her only other medication was ketoprofen, which she had been receiving for 18 months. Screening for hepatitis A and B, cytomegalovirus, EpsteinBarr, and herpes simplex viruses was negative. Upper abdominal ultrasound was normal, and antibodies to smooth muscle and mitochondria were not detected. A liver biopsy showed a severe acute hepatitis with focal 
